Clinical Trial Update: Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma [Phase 2]

View source ↗

Summary

A Phase II trial of NKTR-102 in bevacizumab-resistant high-grade glioma has completed, with results posted in 2015, evaluating activity in anaplastic astrocytom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligodendroglioma
• Glioblastoma

Drugs mentioned

• NKTR-102

Snippet

Sponsor: Lawrence Recht | Conditions: Anaplastic Astrocytomas, Anaplastic Oligodendrogliomas | Phase 2 | Status: COMPLETED | Results posted: 2015-06-11